Invitrogen scientists will support research programs at the Pharmacogenomics Centre to improve the efficiency and speed with which researchers can identify single nucleotide polymorphisms (SNPs), differences in single
Enrollment of the 24 patients will commence at two sites in the New York City area shortly. All subjects will have been previously diagnosed with secondary hypogonadism and
On February 28, 2008, the company has announced the initial submission of an NDA for Embeda capsules and on April 21, 2008 announced the withdrawal of that new
Bausch & Lomb’s Crystalens accommodating intraocular lens (IOL) was first approved by the FDA in November 2003. The Crystalens HD is said to be the fourth generation of
NuPathe’s NP101 combines its SmartRelief proprietary iontophoretic transdermal technology with sumatriptan, the most widely prescribed treatment for acute migraine in the US and the active ingredient in Imitrex.
Caraco’s Amitriptyline hydrochloride is an antidepressant. Its use is indicated to treat symptoms of depression. It is marketed under the brand name of Elavil, a registered trademark of
In this study, treatment with oral odanacatib 5mg once daily reduced the level of urinary N-telopeptide (uNTx), a commonly used marker of bone resorption (breakdown), by 77% from
Approximately 350 patients were randomized into the study. Based on the completion of randomization, the company expects to have the last patient complete the study in the next
In addition, Lev has received notification from the European Medicines Agency (EMEA) that it is eligible to submit an application for Cinrzye for Community marketing authorization through the
The transaction is valued at approximately $66 million in cash (subject to certain customary purchase price adjustments), $4 million in restricted Qiagen common stock and performance and development
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.